Usability of a novel disposable autoinjector device for ixekizumab: results from a qualitative study and an open-label clinical trial, including patient-reported experience
Kristina Callis Duffin,1 Michael Bukhalo,2 Margaret A Bobonich,3 David Shrom,4 Fangyi Zhao,4 James R Kershner,4 Anne Gill,4 Beth Pangallo,4 Catherine L Shuler,4 Jerry Bagel5 1Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT, 2Arlington Dermatology, Arlington Heigh...
Guardado en:
Autores principales: | Callis Duffin K, Bukhalo M, Bobonich MA, Shrom D, Zhao F, Kershner JR, Gill A, Pangallo B, Shuler CL, Bagel J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a0f1994477f94c28a238eee413853b43 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Human factors validation study of 3 mg sumatriptan autoinjector, for migraine patients
por: Brand-Schieber E, et al.
Publicado: (2016) -
Usability of a new disposable autoinjector platform device: results of a formative study conducted with a broad user population
por: Lange J, et al.
Publicado: (2015) -
Addition Of A Sleeve To The Etanercept Autoinjector (Enbrel® MyClic®) Improves Ease Of Use In Patients With Rheumatoid Arthritis
por: Rekaya N, et al.
Publicado: (2019) -
Generalized tinea versicolor following initiation of ixekizumab therapy
por: Haroon Sayed Alam, BS, et al.
Publicado: (2021) -
Usability of devices for self-injection: results of a formative study on a new disposable pen injector
por: Lange J, et al.
Publicado: (2014)